NXGL official logo NXGL
NXGL 1-star rating from Upturn Advisory
Nexgel Inc (NXGL) company logo

Nexgel Inc (NXGL)

Nexgel Inc (NXGL) 1-star rating from Upturn Advisory
$1.65
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

01/09/2026: NXGL (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

1 star rating from financial analysts

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $6

1 Year Target Price $6

Analysts Price Target For last 52 week
$6 Target price
52w Low $1.45
Current$1.65
52w High $4

Analysis of Past Performance

Type Stock
Historic Profit -41.51%
Avg. Invested days 27
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 01/09/2026

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 15.55M USD
Price to earnings Ratio -
1Y Target Price 6
Price to earnings Ratio -
1Y Target Price 6
Volume (30-day avg) 1
Beta 0.57
52 Weeks Range 1.45 - 4.00
Updated Date 01/9/2026
52 Weeks Range 1.45 - 4.00
Updated Date 01/9/2026
Dividends yield (FY) -
Basic EPS (TTM) -0.4

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -24.69%
Operating Margin (TTM) -24.71%

Management Effectiveness

Return on Assets (TTM) -16.78%
Return on Equity (TTM) -52.83%

Valuation

Trailing PE -
Forward PE 15.2
Enterprise Value 16097326
Price to Sales(TTM) 1.19
Enterprise Value 16097326
Price to Sales(TTM) 1.19
Enterprise Value to Revenue 1.38
Enterprise Value to EBITDA -0.85
Shares Outstanding 8142766
Shares Floating 6913601
Shares Outstanding 8142766
Shares Floating 6913601
Percent Insiders 15.39
Percent Institutions 6.43

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

Nexgel Inc

Nexgel Inc(NXGL) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

Nexgel Inc. is a company focused on the development and commercialization of innovative healthcare products. While specific founding details and early milestones are not widely publicized, the company has been active in pursuing advancements in medical devices and related technologies. Its evolution appears to be driven by a focus on addressing unmet needs in various healthcare segments through technological innovation.

Company business area logo Core Business Areas

  • Medical Device Development and Commercialization: Nexgel Inc. is primarily engaged in the research, development, and commercialization of innovative medical devices. This encompasses a range of products aimed at improving patient outcomes and addressing specific medical challenges.
  • Biotechnology and Pharmaceutical Applications: The company also explores opportunities in biotechnology and pharmaceutical applications, potentially involving the development of novel drug delivery systems or therapeutic solutions.

leadership logo Leadership and Structure

Information regarding Nexgel Inc.'s specific leadership team and detailed organizational structure is not readily available in public domain. As a publicly traded company, it is expected to have a board of directors and executive management responsible for its strategic direction and operations.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • Description: Nexgel Inc. is known for developing advanced materials and technologies, particularly in the realm of hydrogels, which have applications in various medical fields. These may include wound care, drug delivery, and medical implants. Specific market share data for individual products is not publicly available.
  • Product Name: Nexgel's proprietary technologies (specific product names not widely disclosed)

Market Dynamics

industry overview logo Industry Overview

Nexgel Inc. operates within the broader medical device and healthcare technology sectors. This industry is characterized by rapid innovation, significant R&D investment, stringent regulatory requirements, and a growing demand driven by an aging global population and increasing prevalence of chronic diseases. Competition is intense, with both established players and emerging startups vying for market share.

Positioning

Nexgel Inc. appears to position itself as an innovator in advanced material science, particularly hydrogel technology, aiming to create novel solutions for unmet medical needs. Its competitive advantage may lie in its proprietary technology and its ability to develop specialized applications in niche healthcare markets.

Total Addressable Market (TAM)

The Total Addressable Market for Nexgel Inc.'s potential product applications, such as advanced wound care, drug delivery systems, and medical implants, is substantial and continues to grow. Precise figures for Nexgel's specific TAM are not readily available, but the overall market for these segments runs into billions of dollars globally. Nexgel Inc. is positioned to target specific niches within this broad TAM, leveraging its technological expertise.

Upturn SWOT Analysis

Strengths

  • Proprietary hydrogel technology
  • Focus on innovation and unmet medical needs
  • Potential for diverse applications across healthcare segments

Weaknesses

  • Limited public information on product pipeline and commercialization progress
  • Potentially smaller market presence compared to established competitors
  • Dependence on R&D success and regulatory approvals

Opportunities

  • Growing demand for advanced wound care solutions
  • Expansion into novel drug delivery systems
  • Partnerships with larger healthcare companies for market access
  • Increasing adoption of minimally invasive medical devices

Threats

  • Intense competition from established medical device companies
  • Stringent and evolving regulatory landscape
  • Challenges in product adoption and market penetration
  • Potential for technological obsolescence

Competitors and Market Share

Key competitor logo Key Competitors

  • CorMatrix (now part of Synapse Biomedical Inc.)
  • Celanese Corporation (through its medical-grade polymers)
  • DSM (healthcare materials)

Competitive Landscape

Nexgel Inc. faces competition from companies specializing in advanced materials, medical devices, and drug delivery systems. Its ability to compete will depend on the uniqueness and efficacy of its patented technologies, its speed to market, and its ability to secure strategic partnerships for wider distribution and adoption.

Growth Trajectory and Initiatives

Historical Growth: Information on Nexgel Inc.'s historical growth trends is limited due to the scarcity of publicly reported financial data. The company's growth trajectory is likely tied to the success of its R&D efforts and the commercialization of its innovative technologies.

Future Projections: Specific future growth projections based on analyst estimates for Nexgel Inc. are not readily available in public financial reports. The company's future growth will depend on its ability to successfully bring its developed products to market and gain traction in its target segments.

Recent Initiatives: Recent strategic initiatives for Nexgel Inc. are not extensively publicized. The company's focus is likely on continued product development, seeking partnerships, and navigating the regulatory pathway for its innovations.

Summary

Nexgel Inc. operates in the innovative healthcare sector with a focus on advanced materials like hydrogels. The company's strengths lie in its proprietary technology and potential for diverse medical applications. However, a lack of readily available public financial and operational data makes a comprehensive assessment challenging. Key areas to watch are its ability to secure funding, navigate regulatory hurdles, and successfully commercialize its innovations in a competitive market.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • General industry knowledge
  • Publicly available company information (limited)

Disclaimers:

This JSON output is based on publicly available information and general industry knowledge. Specific financial data and detailed operational information for Nexgel Inc. are not consistently available in the public domain. Investors should conduct their own thorough due diligence and consult with financial professionals before making any investment decisions. Market share data for Nexgel Inc. and its competitors is not precisely quantifiable without specific reporting. This analysis is for informational purposes only and does not constitute investment advice.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Nexgel Inc

Exchange NASDAQ
Headquaters Langhorne, PA, United States
IPO Launch date 2021-12-22
CEO, President & Director Mr. Adam R. Levy
Sector Healthcare
Industry Medical Instruments & Supplies
Full time employees 19
Full time employees 19

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing NEXDrape, an incise surgical drape designed for patients with impaired skin; and NEXDerm, an adhesive tape designed to secure central lines and intravenous tubes and devices to patients before, during, and after medical treatment. In addition, the company engages in the converting and packaging business. It serves its customers under Medagel, Lumagel Beauty, Kenkoderm and Silly George brand names. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was incorporated in 2009 and is based in Langhorne, Pennsylvania.